These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35304068)

  • 1. Microbiota-targeted therapies in inflammation resolution.
    Strati F; Lattanzi G; Amoroso C; Facciotti F
    Semin Immunol; 2022 Jan; 59():101599. PubMed ID: 35304068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer.
    Dahiya D; Nigam PS
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation.
    Amoroso C; Perillo F; Strati F; Fantini MC; Caprioli F; Facciotti F
    Cells; 2020 May; 9(5):. PubMed ID: 32429359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota medicine: towards clinical revolution.
    Gebrayel P; Nicco C; Al Khodor S; Bilinski J; Caselli E; Comelli EM; Egert M; Giaroni C; Karpinski TM; Loniewski I; Mulak A; Reygner J; Samczuk P; Serino M; Sikora M; Terranegra A; Ufnal M; Villeger R; Pichon C; Konturek P; Edeas M
    J Transl Med; 2022 Mar; 20(1):111. PubMed ID: 35255932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbiome: Relationships with disease and opportunities for therapy.
    Durack J; Lynch SV
    J Exp Med; 2019 Jan; 216(1):20-40. PubMed ID: 30322864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
    Mishima Y; Sartor RB
    J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment.
    Guo XY; Liu XJ; Hao JY
    J Dig Dis; 2020 Mar; 21(3):147-159. PubMed ID: 32040250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Gut Microbiota in Complex Human Diseases.
    Yu D; Meng X; de Vos WM; Wu H; Fang X; Maiti AK
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prebiotics and Probiotics in Digestive Health.
    Quigley EMM
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):333-344. PubMed ID: 30267869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut microbiome and HIV-1 pathogenesis: a two-way street.
    Dillon SM; Frank DN; Wilson CC
    AIDS; 2016 Nov; 30(18):2737-2751. PubMed ID: 27755100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
    Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy.
    Kang Y; Cai Y
    J Hosp Infect; 2017 Aug; 96(4):342-348. PubMed ID: 28545829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.
    Holmes A; Finger C; Morales-Scheihing D; Lee J; McCullough LD
    Transl Res; 2020 Dec; 226():39-56. PubMed ID: 32755639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Link between Gut Microbiota and Hepatic Encephalopathy.
    Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.